[Advances in the study of anti-silicotic agents].
D000535:Aluminum / Q000627:therapeutic use*; D000818:Animals; D006801:Humans; D011144:Polyvinylpyridine N-Oxide / Q000627:therapeutic use*; D011145:Polyvinyls / Q000627:therapeutic use*; D011804:Quinolines / Q000627:therapeutic use*; D011814:Quipazine / Q000627:therapeutic use*; D012829:Silicosis / Q000188:drug therapy*
D011145:Polyvinyls; D011804:Quinolines; D011814:Quipazine; D011144:Polyvinylpyridine N-Oxide; D000535:Aluminum